SCHEDULE 13G/A: BlackRock Amends Filing, Disclosing 12.4% Passive Stake in Astrana Health, Inc.
Beneficial Ownership Disclosure
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, reporting a 12.4% beneficial ownership stake in Astrana Health, Inc.'s common stock as of March 31, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 6,234,446 shares of Astrana Health, Inc. common stock.
- This ownership represents 12.4% of the total outstanding common stock of Astrana Health, Inc.
- The filing date for this Schedule 13G Amendment No. 6 is April 17, 2025, with the event date requiring the filing being March 31, 2025.
- BlackRock holds sole voting power over 6,185,606 shares and sole dispositive power over 6,234,446 shares.
- The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Astrana Health, Inc.
- iShares Core S&P Small-Cap ETF, a fund managed by a BlackRock subsidiary (BlackRock Fund Advisors), is identified as having an interest of more than five percent of the total outstanding common stock of Astrana Health, Inc.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. The filing is a routine disclosure of a passive institutional stake. While a large holding by BlackRock is generally a positive signal, the document itself does not convey specific sentiment about the company's performance or future prospects beyond the fact of investment.
Positives
- A major institutional investor like BlackRock holding a significant 12.4% stake can signal institutional confidence in Astrana Health, Inc.
- The filing explicitly states the shares are held in the ordinary course of business and not for control, indicating a passive investment approach, which can be viewed positively by management and other shareholders.
Risks
- This document, a Schedule 13G, is a disclosure of beneficial ownership and does not contain information regarding the operational or financial risks of Astrana Health, Inc.
Future Outlook
This Schedule 13G filing is a disclosure of beneficial ownership by an institutional investor and does not contain forward-looking statements or guidance regarding Astrana Health, Inc.'s future operational or financial outlook.
Management Comments
- BlackRock, Inc. certified that the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing indicates that Astrana Health, Inc. is a component of investment portfolios managed by large institutional asset managers like BlackRock. The specific mention of iShares Core S&P Small-Cap ETF suggests Astrana Health, Inc. is likely included in small-cap indices, positioning it within a segment of the healthcare industry that attracts passive institutional investment.
Comparison to Industry Standards
- This document is a beneficial ownership disclosure and does not provide financial or operational results for Astrana Health, Inc., thus direct comparison to industry performance standards is not applicable.
- The fact that iShares Core S&P Small-Cap ETF holds a significant stake implies Astrana Health, Inc. meets the criteria for inclusion in the S&P SmallCap 600 Index, which is a benchmark for small-cap U.S. equities. This suggests the company is recognized as a viable investment within the small-cap segment by a leading index provider and asset manager.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional holding, which can influence investor perception and confidence.
- Company Management: Awareness of a major passive institutional investor on their shareholder register.
Next Steps
- BlackRock, Inc. will continue to monitor its investment in Astrana Health, Inc. and file further amendments to its Schedule 13G as required by SEC regulations if its beneficial ownership changes significantly.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney dated, which was expressly revoked by the new Power of Attorney. |
| 2025-01-21 | Execution date of the new Power of Attorney by BlackRock, Inc. |
| 2025-03-31 | Date of event which requires the filing of this statement (beneficial ownership calculation date). |
| 2025-04-17 | Date of signing of the Schedule 13G filing by BlackRock, Inc. |
Keywords
Astrana Health, BlackRock, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, Healthcare, Asset Management, iShares
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.